All news articles for July 2005

R&D spending per NME declines

R&D spending per NME declines

According to a recent survey, the pharma industry spent an
estimated $1.25 billion for each new molecular entity (NME)
approved by the FDA in 2004. The figure represents the second
consecutive year in which this figure has declined...